Pistilli B, Jhaveri K, Im SA, Pernas S, et al. Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone-receptor-positive HER2-negative breast cancer: final overall survival analysis of the phase 3 TROPION-Breast01 study. Ann Oncol 2025 Dec 23:S0923-7534(25)06337-9. doi: 10.1016/j.annonc.2025.
PMID: 41448362